During the past decade, Cancer Center of Kansas - Parsons conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 228 clinical trials were completed, i.e. on average, 296.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 79 clinical trials were completed. i.e. 658.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Center of Kansas - Parsons" #1 sponsor was "National Cancer Institute (NCI)" with 114 trials, followed by "Alliance for Clinical Trials in Oncology" with 97 trials sponsored, "SWOG Cancer Research Network" with 94 trials sponsored, "Eastern Cooperative Oncology Group" with 21 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center of Kansas - Parsons" #1 collaborator was "National Cancer Institute (NCI)" with 264 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator and "Eastern Cooperative Oncology Group" with 11 trials as a collaborator. Other collaborators include 66 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Center of Kansas - Parsons" are "Breast Cancer" (47 trials), "Lung Cancer" (24 trials), "Lymphoma" (22 trials), "Leukemia" (15 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials). Many other conditions were trialed in "Cancer Center of Kansas - Parsons" in a lesser frequency.

Most popular intervention types in "Cancer Center of Kansas - Parsons" are "Drug" (308 trials), "Other" (184 trials), "Biological" (136 trials), "Procedure" (62 trials) and "Radiation" (53 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (88 trials), "Quality-of-Life Assessment" (46 trials), "placebo" (37 trials), "Paclitaxel" (31 trials) and "radiation therapy" (24 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center of Kansas - Parsons" are 292 trials for "All" genders, 78 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Center of Kansas - Parsons". undefined are not yet recruiting, 20 are recruiting, 89 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 233 completed trials in Cancer Center of Kansas - Parsons, 1 suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center of Kansas - Parsons, 18 "Phase 1" clinical trials were conducted, 200 "Phase 2" clinical trials and 153 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".